Bernstein reiterates Outperform on Sun Pharma; ₹2,235 target
Bernstein retained its 'Outperform' recommendation on Sun Pharmaceutical Industries Ltd. and set a price target of ₹2,235 per share, citing expectations around dividends and buybacks between FY27-29.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.